UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
Authors
Keywords
-
Journal
CHINESE MEDICAL JOURNAL
Volume 134, Issue 20, Pages 2465-2474
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-10-08
DOI
10.1097/cm9.0000000000001708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
- (2020) Zhaowu Ma et al. SEMINARS IN CANCER BIOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification and characterization of two novel oncogenic mTOR mutations
- (2019) Avaniyapuram Kannan Murugan et al. ONCOGENE
- UBE2C Functions as a Potential Oncogene by Enhancing Cell Proliferation, Migration, Invasion and Drug Resistance in Hepatocellular Carcinoma Cells
- (2019) Yu Xiong et al. BIOSCIENCE REPORTS
- Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
- (2019) Meran Keshawa Ediriweera et al. SEMINARS IN CANCER BIOLOGY
- Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
- (2019) Chamcheu et al. Cells
- Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer
- (2019) VarRuchi Sharma et al. SEMINARS IN CANCER BIOLOGY
- Derlin‐1 exhibits oncogenic activities and indicates an unfavorable prognosis in breast cancer
- (2019) Jinsheng Zeng et al. CELL BIOLOGY INTERNATIONAL
- The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance
- (2019) Yingying Gong et al. MEDICINE
- Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1
- (2019) Jiajia Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- UBE2C promotes the progression of head and neck squamous cell carcinoma
- (2019) Zhenning Jin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells
- (2018) Jiwei Guo et al. EBioMedicine
- Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
- (2018) Francesca Corti et al. CANCER TREATMENT REVIEWS
- The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
- (2017) Nandini Dey et al. PHARMACOLOGY & THERAPEUTICS
- PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
- (2016) Angel Guerrero-Zotano et al. CANCER AND METASTASIS REVIEWS
- Dual RING E3 Architectures Regulate Multiubiquitination and Ubiquitin Chain Elongation by APC/C
- (2016) Nicholas G. Brown et al. CELL
- The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors
- (2015) W. A. van Gemert et al. BREAST CANCER RESEARCH AND TREATMENT
- Secreted factors derived from obese visceral adipose tissue regulate the expression of breast malignant transformation genes
- (2015) A B Crujeiras et al. INTERNATIONAL JOURNAL OF OBESITY
- Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment
- (2013) Y H Park et al. BRITISH JOURNAL OF CANCER
- Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker
- (2013) Chanlu Xie et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole
- (2013) Akhilesh Rawat et al. CELLULAR ONCOLOGY
- Stromal cells in tumor microenvironment and breast cancer
- (2012) Yan Mao et al. CANCER AND METASTASIS REVIEWS
- Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma
- (2011) Prashant Bavi et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
- (2011) Paolo Cirri et al. CANCER AND METASTASIS REVIEWS
- Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker
- (2011) Zhonglin Hao et al. TUMOR BIOLOGY
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now